View ValuationJiangsu Cnano Technology 향후 성장Future 기준 점검 5/6Jiangsu Cnano Technology (는) 각각 연간 41.2% 및 26.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 41.4% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 15.4% 로 예상됩니다.핵심 정보41.2%이익 성장률41.43%EPS 성장률Chemicals 이익 성장29.8%매출 성장률26.8%향후 자기자본이익률15.41%애널리스트 커버리지Low마지막 업데이트29 Jun 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026Declared Dividend • Jun 26Dividend reduced to CN¥0.083Dividend of CN¥0.083 is 43% lower than last year. Ex-date: 30th June 2026 Payment date: 30th June 2026 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (14% earnings payout ratio) and cash flows (89% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 182% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Yonghong Yang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu China공시 • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026공시 • Dec 26Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026공시 • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025공시 • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025공시 • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 China Standard Time. Location: No. 113, Qinglongshan Road, New District, Zhenjiang, Jiangsu China공시 • Mar 28Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025공시 • Jan 11Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 100 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 63.47 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.공시 • Dec 27Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025New Risk • Nov 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 34%After last week's 34% share price gain to CN¥38.47, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 30% over the past year.Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 3Q 2023). Revenue: CN¥393.7m (down 5.6% from 3Q 2023). Net income: CN¥67.1m (down 6.3% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥26.15, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 2.5% over the past year.New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.7% average weekly change).공시 • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥24.48, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past year.Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥339.5m (down 6.3% from 2Q 2023). Net income: CN¥61.7m (up 23% from 2Q 2023). Profit margin: 18% (up from 14% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.공시 • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024공시 • Apr 29Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 09:00 China Standard Time. Location: The Company's Meeting Room, Zhenjiang, Jiangsu ChinaReported Earnings • Apr 27Full year 2023 earnings releasedFull year 2023 results: Revenue: CN¥1.40b (down 24% from FY 2022). Net income: CN¥297.2m (down 30% from FY 2022). Profit margin: 21% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥24.76, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.공시 • Mar 29Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥19.62, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥22.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (26% accrual ratio).Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.36 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.36 in 3Q 2022). Revenue: CN¥417.3m (down 17% from 3Q 2022). Net income: CN¥71.6m (down 42% from 3Q 2022). Profit margin: 17% (down from 25% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥29.44, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 1.8% over the past three years.Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.30 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥362.3m (down 21% from 2Q 2022). Net income: CN¥50.1m (down 52% from 2Q 2022). Profit margin: 14% (down from 23% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.공시 • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥53.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years.Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 25Full year 2022 earnings released: EPS: CN¥1.77 (vs CN¥1.28 in FY 2021)Full year 2022 results: EPS: CN¥1.77 (up from CN¥1.28 in FY 2021). Revenue: CN¥1.84b (up 39% from FY 2021). Net income: CN¥411.0m (up 39% from FY 2021). Profit margin: 22% (in line with FY 2021). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥83.82, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Xinxin Wang was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥110, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 294% over the past three years.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.36 in 3Q 2021). Revenue: CN¥501.1m (up 29% from 3Q 2021). Net income: CN¥123.7m (up 49% from 3Q 2021). Profit margin: 25% (up from 21% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.45 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.45 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥460.8m (up 52% from 2Q 2021). Net income: CN¥104.2m (up 55% from 2Q 2021). Profit margin: 23% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 85%, compared to a 42% growth forecast for the Chemicals industry in China.Board Change • Jun 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). Director Ge Yan was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.이익 및 매출 성장 예측XSSC:688116 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20282,532804N/A1,174212/31/20272,579677N/A605412/31/20261,744439N/A51533/31/20261,27822634326N/A12/31/20251,297228-39234N/A9/30/20251,40926422325N/A6/30/20251,455251-25250N/A3/31/20251,476255-140160N/A12/31/20241,448250-126276N/A9/30/20241,386318-185180N/A6/30/20241,410323-194257N/A3/31/20241,433311-345328N/A12/31/20231,404297-291299N/A9/30/20231,457258-332340N/A6/30/20231,541310-402289N/A3/31/20231,640364-220154N/A12/31/20221,842424-322108N/A9/30/20221,851420-386-47N/A6/30/20221,739380-462-98N/A3/31/20221,582343-3602N/A12/31/20211,320296-25029N/A9/30/20211,068234-18446N/A6/30/2021834195-1875N/A3/31/2021630148-2576N/A12/31/2020472107-6365N/A9/30/202040196-29101N/A6/30/202035991-5181N/A3/31/202035198-5573N/A12/31/2019386110N/A114N/A9/30/2019393113N/A82N/A3/31/201937086N/A16N/A12/31/201832868N/A-57N/A12/31/2017308-15N/A-22N/A12/31/201613410N/A-5N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 688116 의 연간 예상 수익 증가율(41.2%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 688116 의 연간 수익(41.2%)이 CN 시장(27.5%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 688116 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 688116 의 수익(연간 26.8%)이 CN 시장(연간 16.8%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 688116 의 수익(연간 26.8%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 688116의 자본 수익률은 3년 후 15.4%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/06 15:08종가2026/07/03 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 세부 정보는 당사의 Github 페이지에서 확인하실 수 있으며, 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Jiangsu Cnano Technology Co., Ltd.는 7명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Han YuChina International Capital Corporation LimitedWeichen WuCitic Securities Co., Ltd.Weiqi WangGuosen Securities Co., Ltd.4명의 분석가 더 보기
공시 • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2026 Results on Aug 25, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2026 results on Aug 25, 2026
Declared Dividend • Jun 26Dividend reduced to CN¥0.083Dividend of CN¥0.083 is 43% lower than last year. Ex-date: 30th June 2026 Payment date: 30th June 2026 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (14% earnings payout ratio) and cash flows (89% cash payout ratio). The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 182% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Jun 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥38.24, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 35% over the past three years.
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Yonghong Yang was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 20, 2026, at 09:00 China Standard Time. Location: No. 520, Changshun Road, Wujin District, Changzhou, Jiangsu China
공시 • Mar 30Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026
공시 • Dec 26Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026
공시 • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2025 Results on Oct 27, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
공시 • Jun 30Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025
공시 • Apr 30Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 28, 2025, at 09:00 China Standard Time. Location: No. 113, Qinglongshan Road, New District, Zhenjiang, Jiangsu China
공시 • Mar 28Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025
공시 • Jan 11Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces an Equity Buyback for CNY 100 million worth of its shares.Jiangsu Cnano Technology Co., Ltd. (SHSE:688116) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of class A shares. The shares will be repurchased at a price of not more than CNY 63.47 per share. The shares purchased will be used for the company's equity incentive plans and/or employee stock ownership plans. The program will be funded out of the company's own funds. The program will be valid till 12 months.
공시 • Dec 27Jiangsu Cnano Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 30, 2025Jiangsu Cnano Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 30, 2025
New Risk • Nov 14New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risk Paying a dividend despite having no free cash flows.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improves as stock rises 34%After last week's 34% share price gain to CN¥38.47, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 30% over the past year.
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.21 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.19 (down from CN¥0.21 in 3Q 2023). Revenue: CN¥393.7m (down 5.6% from 3Q 2023). Net income: CN¥67.1m (down 6.3% from 3Q 2023). Profit margin: 17% (in line with 3Q 2023). Revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Oct 15Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to CN¥26.15, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 2.5% over the past year.
New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.7% average weekly change).
공시 • Sep 30Jiangsu Cnano Technology Co., Ltd. to Report Q3, 2024 Results on Oct 26, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥24.48, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 5.0% over the past year.
Reported Earnings • Aug 31Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.14 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.14 in 2Q 2023). Revenue: CN¥339.5m (down 6.3% from 2Q 2023). Net income: CN¥61.7m (up 23% from 2Q 2023). Profit margin: 18% (up from 14% in 2Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 33% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China.
공시 • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024
공시 • Apr 29Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024Jiangsu Cnano Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 09:00 China Standard Time. Location: The Company's Meeting Room, Zhenjiang, Jiangsu China
Reported Earnings • Apr 27Full year 2023 earnings releasedFull year 2023 results: Revenue: CN¥1.40b (down 24% from FY 2022). Net income: CN¥297.2m (down 30% from FY 2022). Profit margin: 21% (down from 23% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China.
Valuation Update With 7 Day Price Move • Apr 03Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥24.76, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 43% over the past year.
공시 • Mar 29Jiangsu Cnano Technology Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024Jiangsu Cnano Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024
Valuation Update With 7 Day Price Move • Feb 12Investor sentiment improves as stock rises 25%After last week's 25% share price gain to CN¥19.62, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total loss to shareholders of 58% over the past three years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥22.20, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 54% over the past three years.
New Risk • Jan 17New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 7.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (7.9% average weekly change). High level of non-cash earnings (26% accrual ratio).
Reported Earnings • Nov 01Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.36 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.36 in 3Q 2022). Revenue: CN¥417.3m (down 17% from 3Q 2022). Net income: CN¥71.6m (down 42% from 3Q 2022). Profit margin: 17% (down from 25% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (33% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).
Valuation Update With 7 Day Price Move • Oct 30Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥29.44, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 1.8% over the past three years.
Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.30 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.14 (down from CN¥0.30 in 2Q 2022). Revenue: CN¥362.3m (down 21% from 2Q 2022). Net income: CN¥50.1m (down 52% from 2Q 2022). Profit margin: 14% (down from 23% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 42% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
공시 • Jun 28Jiangsu Cnano Technology Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023Jiangsu Cnano Technology Co., Ltd. announced that they will report first half, 2023 results on Aug 30, 2023
New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change).
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to CN¥53.09, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 51% over the past three years.
Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 21First quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.43 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.17 (down from CN¥0.43 in 1Q 2022). Revenue: CN¥278.7m (down 42% from 1Q 2022). Net income: CN¥39.7m (down 60% from 1Q 2022). Profit margin: 14% (down from 21% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 56% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 25Full year 2022 earnings released: EPS: CN¥1.77 (vs CN¥1.28 in FY 2021)Full year 2022 results: EPS: CN¥1.77 (up from CN¥1.28 in FY 2021). Revenue: CN¥1.84b (up 39% from FY 2021). Net income: CN¥411.0m (up 39% from FY 2021). Profit margin: 22% (in line with FY 2021). Revenue is forecast to grow 48% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥83.82, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 185% over the past three years.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 6 non-independent directors. Independent Director Xinxin Wang was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 05Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥110, the stock trades at a forward P/E ratio of 31x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 294% over the past three years.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.53 (up from CN¥0.36 in 3Q 2021). Revenue: CN¥501.1m (up 29% from 3Q 2021). Net income: CN¥123.7m (up 49% from 3Q 2021). Profit margin: 25% (up from 21% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 49% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China.
Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.45 (vs CN¥0.29 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.45 (up from CN¥0.29 in 2Q 2021). Revenue: CN¥460.8m (up 52% from 2Q 2021). Net income: CN¥104.2m (up 55% from 2Q 2021). Profit margin: 23% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 85%, compared to a 42% growth forecast for the Chemicals industry in China.
Board Change • Jun 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 1 independent director (7 non-independent directors). Director Ge Yan was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.